688276.SH

Aug 20, 2026, 11:30 UTC

Baike Biological announced its 2026 first-half results: net loss attributable to shareholders narrowed to 52.1001 million yuan from 73.5734 million yuan a year earlier, with revenue up 6.89% to 305 million yuan.